{"DataElement":{"publicId":"6845826","version":"1","preferredName":"Cytogenetic Abnormality Recurrent Chromosomal Translocation Process Type","preferredDefinition":"The response indicating the type of recurrent chromosomal translocation identified.","longName":"REC_CHROM_TRANS_TYP","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"6845807","version":"1","preferredName":"Cytogenetic Abnormality Recurrent Chromosomal Translocation Process","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material._occurring again._Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","longName":"2459195v1.0:6845805v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2459195","version":"1","preferredName":"Cytogenetic Abnormality","preferredDefinition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","longName":"C2950","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Abnormality","conceptCode":"C2950","definition":"An irregularity in the number or structure of chromosomes, usually in the form of a gain (duplication), loss (deletion), exchange (translocation), or alteration in sequence (inversion) of genetic material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F0AEBD7-9460-60D5-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-15","modifiedBy":"ONEDATA","dateModified":"2006-03-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6845805","version":"1","preferredName":"Recurrent Chromosomal Translocation Process","preferredDefinition":"occurring again.:Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","longName":"C14173:C25756","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation Process","conceptCode":"C25756","definition":"Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2CEA5F-BAD1-6A4D-E053-F662850A6EDB","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2CEA5F-BAE2-6A4D-E053-F662850A6EDB","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"HARTLEYG","dateModified":"2019-08-05","changeDescription":"Curated to support protocol 10264","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6845808","version":"1","preferredName":"Chromosomal Translocation Process Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6845808v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other, specify","valueDescription":"Other","ValueMeaning":{"publicId":"6424136","version":"1","preferredName":"Other","longName":"6424136","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"753441A1-068C-5A23-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2018-09-06","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2018-09-06","modifiedBy":"KUMMEROA","dateModified":"2023-02-02","changeDescription":null,"administrativeNotes":"2023.2.2 Alt VM added per ticket request CADSR0002006. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F2C6426-E35B-73D4-E053-F662850A6B7A","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","deletedIndicator":"No"},{"value":"t(3q26;x)","valueDescription":"3q Abnormality Chromosomal Translocation Process","ValueMeaning":{"publicId":"6845810","version":"1","preferredName":"3q Abnormality Chromosomal Translocation Process","longName":"6845810","preferredDefinition":"An irregularity in the structure of the long arm of chromosome 3.: Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"3q Abnormality","conceptCode":"C158849","definition":"An irregularity in the structure of the long arm of chromosome 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation Process","conceptCode":"C25756","definition":"Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2C6426-E36A-73D4-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F2C6426-E383-73D4-E053-F662850A6B7A","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","deletedIndicator":"No"},{"value":"t(11q23;x)","valueDescription":"11q23 Abnormality Chromosomal Translocation Process","ValueMeaning":{"publicId":"6845811","version":"1","preferredName":"11q23 Abnormality Chromosomal Translocation Process","longName":"6845811","preferredDefinition":"Any cytogenetic abnormality involving chromosome band 11q23.: Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"11q23 Abnormality","conceptCode":"C158685","definition":"Any cytogenetic abnormality involving chromosome band 11q23.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Chromosomal Translocation Process","conceptCode":"C25756","definition":"Any type of genetic recombination involving exchange of DNA between non-homologous chromosomes, which often occurs as the result of non-homologous end-joining of broken DNA strands. Chromosomal translocation is involved in repairing broken DNA and in maintaining cell viability at the expense of long term genomic stability. This process is is associated with particular types of leukemia, infertility and Down Syndrome.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2C6426-E390-73D4-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F2C6426-E3A9-73D4-E053-F662850A6B7A","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","deletedIndicator":"No"},{"value":"Philadelphia","valueDescription":"Philadelphia Chromosome","ValueMeaning":{"publicId":"2939336","version":"1","preferredName":"Philadelphia Chromosome","longName":"2939336","preferredDefinition":"An abnormality of chromosome 22 in which part of chromosome 9 is transferred to it.  Bone marrow cells that contain the Philadelphia chromosome are often found in chronic myelogenous leukemia.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Philadelphia Chromosome","conceptCode":"C28452","definition":"A translocation between chromosomes 9 and 22. It is the hallmark for chronic myelogenous leukemia (CML).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"732CDE95-7DA5-9757-E040-BB89AD4318E5","latestVersionIndicator":"Yes","beginDate":"2009-09-09","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F2C6426-E3BD-73D4-E053-F662850A6B7A","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","deletedIndicator":"No"},{"value":"CBF","valueDescription":"Core-Binding Factor","ValueMeaning":{"publicId":"6845812","version":"1","preferredName":"Core-Binding Factor","longName":"6845812","preferredDefinition":"CBF is an alpha/beta heterodimeric transcription factor involved in the transcriptional regulation of several genes important in hematopoiesis.  The CBFalpha subunit binds directly to the enhancer core DNA sequence on target genes, whereas the beta subunit does not bind the DNA directly but increases the affinity and stabilizes the binding of the alpha subunit to the DNA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Core-Binding Factor","conceptCode":"C17683","definition":"CBF is an alpha/beta heterodimeric transcription factor involved in the transcriptional regulation of several genes important in hematopoiesis.  The CBFalpha subunit binds directly to the enhancer core DNA sequence on target genes, whereas the beta subunit does not bind the DNA directly but increases the affinity and stabilizes the binding of the alpha subunit to the DNA.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2C6426-E3CA-73D4-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8F2C6426-E3E3-73D4-E053-F662850A6B7A","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"ONEDATA","dateModified":"2019-08-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435029","version":"1","preferredName":"Molecular Abnormality","preferredDefinition":"Abnormalities that occur in human cells and tissues and models of human cancer.","longName":"C3910","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07432BB3-787B-25DB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2C6426-E33A-73D4-E053-F662850A6B7A","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"HARTLEYG","dateModified":"2019-08-05","changeDescription":"Curated to support protocol 10264","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"If Present, please select","type":"Preferred Question Text","description":"If Present, please select","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F2D4FE9-DDDD-7193-E053-F662850AE225","latestVersionIndicator":"Yes","beginDate":"2019-08-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-08-02","modifiedBy":"HARTLEYG","dateModified":"2019-08-05","changeDescription":"Curated to support protocol 10264","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}